Search results
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this session, Prof Nicolas Van Mieghem and Dr Joost Daemen(Erasmus Medical Center, Rotterdam, NL) combine presentation, case review, and discussion to provide expert insight into TAVI access options with IVL. This programme addresses the challenges associated with problematic calcium, examines the role of IVL in cracking calcium in situ, and highlights the importance of its mechanism of action…
View more
Overcoming the Challenges of the Transfemoral Approach in Transcatheter Aortic Valve Implantation
Author(s):
Stephane Noble
,
Marco Roffi
Added:
3 years ago
Article
Author(s):
Holger Eggebrecht
,
Philipp Kahlert
,
Polykarpos Patsalis
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has recently emerged as a novel, minimally invasive treatment option for patients with symptomatic severe aortic valve stenosis deemed at high risk of conventional surgery due to excessive co-morbidities.1,2 Clinical results of TAVI are encouraging and the number of patients treated with this new method continues to grow exponentially in an…
View more
Author(s):
Didier Tchétché
,
Chiara de Biase
,
Bruno Brochado
,
et al
Added:
3 years ago
Sixteen years have elapsed since the first transcatheter aortic valve implantation (TAVI) and the procedure has now been widely adopted. The first time the procedure was performed, the patient was under conscious sedation with local anaesthesia for an antegrade-transseptal procedure.1 The pioneering team in Rouen published a series of case reports for patients treated via a transfemoral route…
View more
Author(s):
Firas Zahr
Added:
2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral…
View more
Author(s):
Alia Noorani
,
Vinayak Bapat
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal…
View more
Author(s):
Dr Won-Keun Kim
Start date:
Oct 23, 2018
Transcatheter aortic valve implantation (TAVI) has emerged to be a viable treatment option for patients suffering from Severe Aortic Stenosis.
The transfemoral approach is the most common access route for TAVI and associated with most favourable clinical outcomes.
However, with a population with increasingly complex vasculature, the incidence of vascular complications in TAVI remains high…
View more
Author(s):
Crochan J O’Sullivan
,
Peter Wenaweser
Added:
3 years ago
Since the first ‘proof-of-concept’ case of transcatheter aortic valve implantation (TAVI) was reported by Cribier and colleagues in 2002, more than 200,000 patients have undergone the procedure in approximately 65 countries.1,2 Since its inception, the majority of patients undergoing TAVI have been considered inoperable or high risk for conventional surgical aortic valve replacement (SAVR) as…
View more
JIM 2019 Live Cases
Video Series
Author(s):
Pierluigi Costanzo
,
Paul Bamborough
,
Mark Peterson
,
et al
Added:
1 year ago